Código QR (código de barras bidimensional)

Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis

  Background: Adalimumab is approved for Rheumatoid Arthritis (RA). In 2021, A biosimilar (ABP501;Amgevita®) was licensed in Iraq. The current study aimed to ensure safety and Efficacy of Amgevita in RA Patients in Iraq. Patients and Methods: A Cross sectional Observational study Started on 69...

Fuld beskrivelse

Na minha lista:
Principais autores: Yasameen Abbas, Nabaa Ihsan, Asal Adnan, Marwa Moayad, Ali AlKazzaz, Avin Maroof, Ali Abdulrahman, Nazar Abdulateef, Mohammad AlOsami, Faiq Gorial, Mohammed Altahhan, Zahraa Almansi, Ali Alnoori
Format: Artigo
Sprog:Inglês
Udgivet: University of Baghdad/ Al-Kindy College of Medicine 2024-12-01
Serier:مجله كليه طب الكندي
Fag:
Rheumatoid arthritis
Biosimilar
Adalimumab
Online adgang:https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/1476
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker